bet-at-home.com AG (0RIP)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 2.655 |
|---|---|
| 52-week range | 1.970 – 3.890 |
| Return, 1 month / 3 months | −15.0% / −15.3% |
| Return, 1 year / 3 years | +4.1% / −28.0% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 63.9% |
| Worst drawdown (1 year) | -29.2% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
bet-at-home.com AG is an online gambling company based in Austria that runs a sports betting and gaming platform. It offers customers bets on sporting events along with casino-style games such as slots and table games, all through its website and mobile services. Its customers are mainly recreational players in German-speaking and other European markets. The company operates as part of a larger European online gaming group.
On this site bet-at-home.com AG appears as a stock on the London Stock Exchange (UK), code 0RIP, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
bet-at-home.com AG (0RIP) trades on the London Stock Exchange in UK. It last closed at EUR 2.655 on 27 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,753 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.1% and over the last three months it fell 15.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.3% | ||
| From 52-week high | -29.2% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -15.3% | ||
| 6-month return | 7.9% | ||
| 12-month return, skipping the last month | 22.5% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 63.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.2% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 43.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −5.9% |
|---|---|
| 1 month | −15.0% |
| 3 months | −15.3% |
| 6 months | +7.9% |
| 1 year | +4.1% |
| 3 years | −28.0% |
| 5 years | −85.5% |
Signals
| 50-day / 200-day average | 3.108 / 2.834 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.204 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 May 2021 | EUR 2.5000 |
| 8 Jul 2020 | EUR 2.0000 |
| 23 May 2019 | EUR 3.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.